Mednet Logo
HomeQuestion

How would you approach therapy for newly diagnosed germinal-center DLBCL who previously received an unknown systemic regimen with radiation for history of Hodgkin Lymphoma?

1
1 Answers
Mednet Member
Mednet Member
Medical Oncology · Cleveland Clinic

A lot of times, you can ask the patient if they received a red medication (doxorubicin) or if their hair fell out to determine prior anthracycline exposure. If you cannot confirm, I would assume that they received ABVD x 6 cycles. This would be a cumulative drug exposure of 300 mg/m^2. Depending on ...

Register or Sign In to see full answer

How would you approach therapy for newly diagnosed germinal-center DLBCL who previously received an unknown systemic regimen with radiation for history of Hodgkin Lymphoma? | Mednet